{"wiki_id": "http://www.wikidata.org/entity/Q5586007", "itemLabel": "Gordon Wishart", "itemDescription": "Scottish medical doctor", "wikipedia_url": "https://en.wikipedia.org/wiki/Gordon_Wishart", "wikipedia_page": {"main": "Professor Gordon C Wishart FRCS FRCS (Eng.) FRCS (Gen.)  (3 September 1960-) is the founder, Chief Medical Officer and CEO of Check4Cancer, a leading early cancer detection and cancer prevention company. In 2016 Check4Cancer launched rapid access, streamlined and audited diagnostic pathways for breast and skin cancer to the insured and self-pay markets, leading to the award of \u201cDiagnostic Provider of the Year\u201d at the annual Health Investor Awards in 2018. In late 2017, Check4Cancer launched the first worldwide breast cancer risk test (MyBreastRisk) to combine genetic, family history and lifestyle risk factors to underpin a risk-stratified breast screening programme. As the former Director of the Cambridge Breast Unit from 2005-2010, and current Professor of Cancer Surgery at Anglia Ruskin School of Medicine since 2008, he has a strong track record in clinical research and modernisation of cancer diagnosis and treatment, with more than 100 peer-reviewed papers in scientific journals. In 2010 he led a team of clinicians and scientists that developed the PREDICT breast cancer treatment and survival model, now used worldwide.", "link_mentions": [{"page": "Wishart", "response": ["* Gordon Wishart (b. 1960), British surgeon"]}, {"page": "Gordon wishart", "response": ["#REDIRECT Gordon Wishart "]}]}}